The government has announced plans to test for cervical cancer in women on an experimental basis.
In October, the government announced the first phase of the test for people aged over 40.
In February, a study revealed that the test could detect cervical cancer.
However, a government spokesperson told The Hindu that the government had not found any evidence of cervical cancer being present in women.
According to the Indian government’s statement, the study was conducted on people aged 20 to 40, and it showed that cervical cancer could be detected in some women.
“However, a woman who has developed cervical cancer after being infected with HPV16-19, or is at a high risk of developing cervical cancer later in life, is not at a risk for cervical disease after vaccination,” the spokesperson said.
However, the spokesperson clarified that there was no proof that cervical cells were being destroyed by the vaccine.
According to Dr Sushil Mishra, who leads the institute at the Centre for Cellular and Molecular Medicine, the researchers have no way of knowing whether the vaccine is working.
“We don’t know how the vaccine works in the cells of a human body.
There is no vaccine that is able to kill the virus in the human body,” he said.
“The vaccine will only be effective in people aged 70-80, or above.
We don’t have any data on how well it is working in women, or whether there are any adverse effects.””
The vaccine does not prevent HPV infection in women but it is an effective tool for women to get cervical cancer-free.”
Dr Mishra said that he did not know if there were any adverse side effects.
“I think it’s possible that the vaccine might be effective for some women but not for all women.
So it is important that we take this issue very seriously.
It is very important that all women, including those who are at high risk, get a vaccine before they are 65,” he added.
According the Indian Health Ministry, cervical cancer is one of the most common cancers.
“Cervical cancer is a cancer of the cervix, which is located in the vagina and the cervicovacervix, and is also known as the vagina cancer,” Dr Mishra explained.
“Women aged 20-40 are at a higher risk of cervical cancers and women over the age of 70- 80 are more likely to have cervical cancer.”
According to Dr Mishras findings, cervical cells, which are found in the cervice and vagina, can be damaged by infection.
“When a person has a virus, this is what happens to the cells.
The cells are destroyed, the DNA is destroyed.
But the cells can be replaced by the virus if the virus has the ability to cause cells to become healthy,” he explained.
“It can be said that cervical tissue is damaged when it is damaged by the HPV virus,” Dr K. Srinivasan, the National Cervical Cancer Research Center Director, told NDTV.
The spokesperson said that the scientists had been studying the effect of the vaccine in mice, and were not ready to comment on the study.
“There are a number of studies that are looking at the effect on the human cells in humans,” Dr Nishankar Singh, head of the Institute of Cellular and Cellular Molecular Medicine at the Center for Cellular Biology at the National Institutes of Health, told The Indian Express.